Cargando…
Influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation
Autores principales: | Pandey, Deep Narayan, Rastogi, Sanjeev, Agarwal, Girdhar Gopal, Lakhotia, S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Sciences and Technology and World Ayurveda Foundation.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414312/ https://www.ncbi.nlm.nih.gov/pubmed/32782113 http://dx.doi.org/10.1016/j.jaim.2020.07.005 |
Ejemplares similares
-
Author's reply to correspondence ‘influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation’
por: Gundeti, Manohar S., et al.
Publicado: (2022) -
Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic – A Cautious Interpretation is Desired Before Any Generalization is Attempted
por: Rastogi, Sanjeev, et al.
Publicado: (2022) -
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study
por: Gundeti, Manohar S., et al.
Publicado: (2022) -
AYUSH- 64: A potential therapeutic agent in COVID-19
por: Panda, Ashok Kumar, et al.
Publicado: (2022) -
Plasma citrulline in the critically ill: intriguing biomarker, cautious interpretation
por: Piton, Gaël, et al.
Publicado: (2015)